Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-01-26

Clinical Trial Update: Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Hip Fracture Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial of DU-176b for prevention of venous thromboembolism after hip fracture surgery completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DU-176b

Snippet

Sponsor: Daiichi Sankyo Co., Ltd. | Conditions: Venous Thromboembolism | Phase 3 | Status: COMPLETED | Results posted: 2015-01-26